Form 4: IGC Pharma Director Richard Prins Reports Stock Transactions
SEC Form 4
Director Richard Prins reports acquisition of common stock through vesting of restricted stock units.
Summary
- Richard Prins, a director of IGC Pharma, reported transactions involving the company's stock on March 13, 2024.
- The transactions involved the vesting of restricted stock units (RSUs) and the acquisition of common stock.
- Prins acquired a total of 426,250 shares of common stock through the vesting of RSUs.
- He also received grants of 210,000 RSUs vesting over three years and 175,000 RSUs vesting upon achievement of milestones.
- Following these transactions, Prins directly owns 1,242,917 shares of IGC Pharma common stock and 938,750 RSUs.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, so the sentiment is neutral. It reflects routine transactions related to executive compensation.
Positives
- The acquisition of shares by a director could be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the ongoing vesting of previously granted equity compensation.
Key Dates
| Date | Description |
|---|---|
| 07/19/2021 | Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2022. |
| 05/25/2022 | Reporting Person was granted RSUs subject to vesting equally over three years starting March 2023. |
| 06/20/2023 | Reporting Person was granted RSUs subject to vesting equally over three years starting March 2024. |
| 06/20/2023 | Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. |
| 03/13/2024 | Date of earliest transaction; RSUs vested and new RSUs granted. |
| 03/13/2024 | Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025. |
| 03/13/2024 | Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. |
| 03/15/2024 | Date of signature. |
| 03/31/2033 | Expiration date for some Restricted Stock Units. |
| 03/31/2034 | Expiration date for some Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.